(Bispecific) Antibodies in Cancer Patients

首次发布于 2021 年 11 月 15 日

Dose Schedule Study of BCMA Bispecific Antibody, Elranatamab, for Newly Diagnosed Immunoglobulin Light Chain (AL) Amyloidosis

计划入组 64 人 · 首次发布于 2026 年 4 月 13 日

CAR-T Followed by Bispecific Antibodies

计划入组 23 人 · 首次发布于 2021 年 5 月 17 日

Bispecific,Zymeworks

ROR1 Bispecific

GT-00X bispecific

Immatics

Germany

Rybrevant Demonstrates Promising Activity in Metastatic Colorectal Cancer

Bispecific Antibodies Emerge as Promising Immunotherapy Backbone in Cancer Treatment

Candid Therapeutics Launches with $370M to Advance Bispecific T-Cell Engagers for Autoimmune Diseases